MYC and Miyoshi myopathy: Also, clinical data revealed that MM patients bearing MYC translocations have decreased progression-free survival (PFS) and overall survival (OS) independently of age, advanced stage, or cooccurrence of high-risk cytogenetic abnormalities [58].